| P50 | author | Marc Peeters | Q38324454 |
| | Alessio Annovazzi | Q73068360 |
| P2093 | author name string | Christophe Van De Wiele | |
| | Rudi Dierckx | |
| | Alberto Signore | |
| | Annelies Maenhout | |
| P2860 | cites work | On the Origin of Cancer Cells | Q27861025 |
| | Relevance of positron emission tomography (PET) in oncology. | Q30581499 |
| | Positron emission tomography and colorectal cancer | Q31893861 |
| | Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography | Q32054377 |
| | 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer | Q33611851 |
| | A prospective evaluation of cytology from biliary strictures. | Q33618121 |
| | Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection | Q33773261 |
| | Positron emission tomography scanning in the evaluation of hepatocellular carcinoma | Q33939061 |
| | Treatment of oesophago-gastric tumours | Q34513549 |
| | Management Strategies in Resection for Hilar Cholangiocarcinoma | Q34537261 |
| | Advances in imaging for pancreatic disease | Q34568520 |
| | Carcinoma of stomach and duodenum: radiologic diagnosis and staging | Q34666903 |
| | Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970 | Q36069967 |
| | Positron emission tomography for staging of oesophageal and gastroesophageal malignancy | Q36115379 |
| | FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study | Q36641933 |
| | CT of the gastrointestinal tract: principles and interpretation | Q37318018 |
| | Liver resection for bile duct cancer. | Q38267376 |
| | Impact of Staging on the Treatment of Hepatocellular Carcinoma | Q40485590 |
| | Thoracoscopic staging and surgical therapy for esophageal cancer | Q40544933 |
| | Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma | Q40700869 |
| | Cancer statistics, 1999. | Q40817780 |
| | CT- and US-guided biopsy of the pancreas | Q40885416 |
| | The imaging science of positron emission tomography | Q41004700 |
| | Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients | Q41090222 |
| | Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer | Q41664193 |
| | Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography | Q41672832 |
| | CT and MR evaluation of pancreatic cancer. | Q41690589 |
| | Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET). | Q43582731 |
| | Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer | Q43601169 |
| | Evaluation of pancreatic carcinoma with FDG PET. | Q43656200 |
| | Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions | Q43761853 |
| | FDG PET in the diagnosis of hilar cholangiocarcinoma | Q43801540 |
| | Selection of patients for curative or palliative resection of esophageal cancer based on preoperative endoscopic ultrasonography | Q43843079 |
| | Fluorine-18 FDG imaging in hepatocellular carcinoma using positron coincidence detection and single photon emission computed tomography | Q43925385 |
| | Whole-body PET with FDG for the diagnosis of recurrent gastric cancer | Q43933728 |
| | Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis? | Q43942303 |
| | Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer | Q43983613 |
| | FDG-PET improves the staging and selection of patients with recurrent colorectal cancer | Q44058909 |
| | Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer | Q44158871 |
| | Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms | Q44175737 |
| | Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality | Q46681699 |
| | Proposed revision of the staging classification for esophageal cancer. | Q50897478 |
| | Patient selection for hepatic resection of colorectal metastases. | Q51035621 |
| | Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. | Q51557814 |
| | Computed tomographic staging of esophageal carcinoma: a study on interobserver variation and correlation with pathological findings | Q52860153 |
| | Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. | Q53530417 |
| | Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. | Q53604465 |
| | Staging of esophageal carcinoma: comparison of results with endoscopic sonography and CT. | Q54189107 |
| | 16. FDG-PET in the Detection of Recurrence in Colorectal Cancer Based on Rising CEA Level. Experience in 72 Patients. | Q54215766 |
| | Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil | Q61868312 |
| | Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography | Q63728661 |
| | Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography. | Q64968833 |
| | Characteristic findings of hepatocellular carcinoma: An evaluation with comparative study of US, CT, and MRI | Q67490546 |
| | Recurrent rectal cancer and scar: differentiation with PET and MR imaging | Q67735215 |
| | Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer | Q68182927 |
| | Imaging of colorectal carcinoma | Q69482531 |
| | Esophagogastric carcinoma: preoperative TNM classification with endosonography | Q69545250 |
| | Recurrence of colorectal tumors: PET evaluation | Q69735196 |
| | Colorectal carcinoma evaluation with CT: preoperative staging and detection of postoperative recurrence | Q69991861 |
| | Pseudotumorous pancreatitis | Q70079123 |
| | Comparative analysis of imaging modalities in the preoperative assessment of nodal metastasis in esophageal cancer | Q71094080 |
| | Surgical management of locally recurrent rectal cancer | Q71147563 |
| | The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver | Q71183559 |
| | [Results of positron emission tomography with fluorine-18 labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma] | Q71460921 |
| | Lymph-node metastases: efficacy for detection with helical CT in patients with gastric cancer | Q71539521 |
| | Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging | Q71816286 |
| | Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation | Q72056086 |
| | An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer | Q72325437 |
| | Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer | Q72424728 |
| | Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography | Q73030448 |
| | Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma | Q73178836 |
| | Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma | Q73194461 |
| | Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy | Q73214545 |
| | Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases | Q73247604 |
| | Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography | Q73288685 |
| | Extended resections for hilar cholangiocarcinoma | Q73313364 |
| | Delayed (18)F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas | Q73338913 |
| | Hepatitis C and hepatocellular carcinoma | Q73717368 |
| | Improvement in staging of esophageal cancer with the addition of positron emission tomography | Q73723186 |
| | Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography | Q73797048 |
| | Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses | Q74081515 |
| | EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma | Q74253544 |
| | Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings | Q74290113 |
| | Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer | Q74397574 |
| | Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer | Q74593433 |
| | Evaluation of benign vs malignant hepatic lesions with positron emission tomography | Q74598745 |
| | MR imaging during arterial portography for assessment of hepatocellular carcinoma: comparison with CT during arterial portography | Q74604766 |
| | Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer | Q74664667 |
| | Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer | Q77443192 |
| | Clinical assessment of positron emission tomography for the diagnosis of local recurrence in colorectal cancer | Q78032287 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | positron emission tomography | Q208376 |
| P304 | page(s) | 1235-1245 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | 18-fluorodeoxyglucose positron emission tomography in nonendocrine neoplastic disorders of the gastrointestinal tract | |
| P478 | volume | 125 | |